Balyasny Asset Management
SHACW

Balyasny Asset Management’s SCP & CO Healthcare Acquisition Company Warrant SHACW Stock Holding History

Balyasny Asset Management’s Portfolio SHACW Stock Details SHACW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-866,250
Closed -$42K – 3492
2022
Q3 		$42K Hold
866,250
– – ﹤0.01% 2497
2022
Q2 		$68K Hold
866,250
– – ﹤0.01% 2328
2022
Q1 		$178K Hold
866,250
– – ﹤0.01% 2044
2021
Q4 		$476K Hold
866,250
– – ﹤0.01% 1633
2021
Q3 		$502K Hold
866,250
– – ﹤0.01% 1478
2021
Q2 		$736K Hold
866,250
– – ﹤0.01% 1430
2021
Q1 		$514K Buy
+866,250
New +$532K ﹤0.01% 1394

Balyasny Asset Management's SHACW Position: Q4 2022 in Review

Balyasny Asset Management sold out of SCP & CO Healthcare Acquisition Company Warrant (SHACW) in Q4 2022, closing a stake of 866,250 shares — an estimated $42K sold.

Balyasny Asset Management first reported a position in SHACW in Q1 2021 and held it in 7 quarters. The position peaked at $736K in Q2 2021. 0 funds tracked by Wall St. Rank hold SHACW as of Q4 2022.

  • Balyasny Asset Management reported no remaining SCP & CO Healthcare Acquisition Company Warrant position as of Q4 2022 after selling out during the quarter.
  • Balyasny Asset Management sold 866,250 SCP & CO Healthcare Acquisition Company Warrant shares in Q4 2022, an estimated $42K.
  • Balyasny Asset Management first reported a position in SCP & CO Healthcare Acquisition Company Warrant in Q1 2021 and held it in 7 quarters.
  • Balyasny Asset Management's SCP & CO Healthcare Acquisition Company Warrant position peaked at $736K in Q2 2021.
  • 0 funds tracked by Wall St. Rank held SCP & CO Healthcare Acquisition Company Warrant as of Q4 2022.

Based on Balyasny Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.